Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

As a passionate advocate for innovation and patient-centered care, I’ve dedicated my career to bridging medical, economic, and regulatory landscapes to drive impactful outcomes. My experience spans over 38 years in biotechnology and pharmaceutical industries, emphasizing payer engagement, HEOR, and lifecycle management. Here is my biography.

I am excited to share my professional journey as a health economist and healthcare strategist with over 17 years of global experience. My work focuses on aligning economic evaluation with innovative healthcare technologies to create sustainable solutions for public and private payers. Here is my biography.